31 October 2019
Visiongain’s new report Bioherbicides Market Report : A global report on bioherbicides market estimate and forecast – Industry insights for consumption, demand, production, price trend, competitive intelligence, and opportunity analysis along the value chain” states that the bioherbicides market was valued at $2.0 billion in 2018 in terms of revenue.
Visiongain offers historical market size for 2016 - 2018, estimate for 2019 and forecast up to 2030. The report also includes consumption data, production capacity, and market share for key players. The market estimation and forecast is done for the application of bioherbicides.
The consumption of bioherbicides market is set to witness significant increase globally, fuelled by the increasing development in integrated pest management and research and development activities globally, increasing regulation on synthetic chemical use, increasing demand for food safety and quality, and increasing demand for organic products. Decreased hazards of chemicals and easier residue management are another factor pertaining towards the growth of global bioherbicides market at rapid pace as herbicides comprises of approximately 50% of the worldwide pesticide market.
The report offers competitive analysis including product benchmarking, production capacity for the year 2018, price trend analysis, regulatory analysis, value chain analysis and supply chain analysis. Industry leaders are majorly focusing on the product differentiation to get an edge over the competitors.
The report includes the following insights, which is intended to help the stakeholders throughout the value chain. The report offers insights of the overall bioherbicides industry and will benefit stakeholders in making right decision at right time.
- Bioherbicides consumption in oil seeds, grains & cereals, fruits & vegetables, turf & ornamental grass, and other industries for historic and forecast period.
- Revenue estimate and forecast.
- Pricing trend analysis for historic period.
- Regulatory framework.
- Raw Material Pricing Analysis
- Opportunity analysis across the value chain and supply chain.
- PESTEL, Porter’s, and SWOT analysis.
- Market dynamics covering trend, drivers, restraints and opportunities.
- Production capacity of leading players.
- Market share analysis of leading players along with their profiles.
- Strategic initiatives taken by industry leaders.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the energy, telecoms, pharmaceutical, defence and materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
What is causing this growth in the market? Primarily it is the growing rubber and plastics industry coupled increased demand for pharmaceuticals and cosmetics from Japan, China, and India.
19 October 2020
The manufacture of cars and aircraft composite products plays a key role. The growing concerns about fuel consumption and pollution carbon emission rates have prompted manufacturers to replace metal parts with carbon fiber composites.
28 September 2020
Growing application in the residential and non-residential industries is projected to positively influence growth as a result of the high visibility of the market in soft flooring products and good insulation properties, including floor insulation.
28 September 2020
Their demand in pharmaceutical and medical applications is projected to increase with numerous health benefits related to essential oils. Essential oil has no significant side-effects, unlike other traditional drugs and medications.